Psychedelics: A New Form of Treatment for Adolescent Depression

Main Article Content

Zain Niazi

Abstract




Depression among adolescents is a rising concern in the United States. This is alarming as evidence shows that the disorder carries many negative long-term effects that make it difficult for adolescents to mature and transition into adulthood. Current antidepressants, such as SSRIs, used to treat the disorder have been found to carry a multitude of side effects making them unfavorable. While some research has found benefits of psychedelics, such as psilocybin and lysergic acid diethylamide (LSD), to treat depression, studying its effects as a viable option is limited because of the Controlled Substance Act. In recent years, though, lawmakers have begun to reevaluate the legality of psychedelics. In this article, the effectiveness and legality of antidepressants and psychedelics for adolescents will be examined in order to offer a new solution for treating adolescent depression.




Downloads

Download data is not yet available.

Article Details

How to Cite
Niazi, Z. (2024). Psychedelics: A New Form of Treatment for Adolescent Depression. The Undergraduate Journal of Law &Amp; Disorder, 7, 73–80. Retrieved from https://scholarworks.iu.edu/journals/index.php/lad/article/view/38284
Section
Articles